Structure Therapeutics, Inc. (GPCR)
25.54
-0.13
(-0.51%)
USD |
NASDAQ |
Oct 09, 14:24
Structure Therapeutics 30-Day Average Daily Volume : 1.366M for Oct. 8, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 08, 2026 | 1.366M |
| October 07, 2026 | 1.366M |
| October 06, 2026 | 1.347M |
| October 05, 2026 | 1.327M |
| October 02, 2026 | 1.284M |
| October 01, 2026 | 1.275M |
| September 30, 2026 | 1.212M |
| September 29, 2026 | 1.162M |
| September 28, 2026 | 1.114M |
| September 25, 2026 | 1.090M |
| September 24, 2026 | 1.052M |
| September 23, 2026 | 1.032M |
| September 22, 2026 | 1.001M |
| September 21, 2026 | 992451.4 |
| September 18, 2026 | 969374.0 |
| September 17, 2026 | 928956.5 |
| September 16, 2026 | 913427.4 |
| September 15, 2026 | 887682.0 |
| September 14, 2026 | 849539.6 |
| September 11, 2026 | 813180.9 |
| September 10, 2026 | 783438.0 |
| September 09, 2026 | 773735.0 |
| September 08, 2026 | 738576.3 |
| September 04, 2026 | 640134.8 |
| September 03, 2026 | 652591.4 |
| Date | Value |
|---|---|
| September 02, 2026 | 654054.1 |
| September 01, 2026 | 639122.9 |
| August 31, 2026 | 621878.6 |
| August 28, 2026 | 588941.6 |
| August 27, 2026 | 599389.2 |
| August 26, 2026 | 610566.0 |
| August 25, 2026 | 602143.3 |
| August 24, 2026 | 605542.7 |
| August 21, 2026 | 594500.8 |
| August 20, 2026 | 599310.1 |
| August 19, 2026 | 567001.5 |
| August 18, 2026 | 571936.2 |
| August 17, 2026 | 569294.9 |
| August 14, 2026 | 576132.6 |
| August 13, 2026 | 577353.0 |
| August 12, 2026 | 617809.6 |
| August 11, 2026 | 607310.6 |
| August 10, 2026 | 617540.7 |
| August 07, 2026 | 635108.7 |
| August 06, 2026 | 655009.9 |
| August 05, 2026 | 669030.1 |
| August 04, 2026 | 690076.9 |
| August 03, 2026 | 699170.8 |
| July 31, 2026 | 726693.2 |
| July 30, 2026 | 747383.5 |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Eli Lilly & Co. | 2.348M |
| Novo Nordisk A/S | 13.33M |
| Pfizer Inc. | 33.11M |
| Viking Therapeutics, Inc. | 6.711M |
| Liquidia Corp. | 3.525M |